Sappe vs Danone SA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Sappe Public Company Limited (SAPPE.BK)

Q3 202623 Jul – 8 Oct 2026

▲3▼1

SAPPE turns the corner: profit growth returns, brokers raise targets

Q2 revenue up 16%, first profit growth in 7 quarters expected SAPPE's Q2 2026 revenue rose 16% to 1.5 billion baht, with net profit up 3.3%, as Asia and US sales recovered. Brokers now expect Q3 to deliver the first year-on-year profit growth in seven quarters, a sign the worst is over.
This is the core fundamental turnaround driving the stock's re-rating.
Brokers lift targets, cite 16% profit growth and cheap valuation Finansia Syrus raised its target to 44 baht, Krungsri kept Buy at 38.50 baht, and Maybank highlighted SAPPE's 16% profit growth in 2027 with the sector's lowest P/E of 12.2x. Multiple upgrades signal growing analyst confidence.
Broker upgrades and target hikes directly influence investor sentiment and buying.
International expansion and new capacity support 10-15% growth SAPPE is expanding in Asia, the Americas, and Europe, targeting 10-15% revenue growth. A new production line in 2027 will add 25-30% capacity. The Indonesia distributor launch was delayed to early 2027 but remains a major opportunity.
Growth strategy and capacity expansion underpin future earnings potential.
US tariffs and rising sugar costs pose headwinds The US imposed a 12.5% tariff on Thai imports, affecting SAPPE's 11% US revenue exposure. Global sugar prices jumped 21%, and SAPPE is seen as most vulnerable due to its high export share. These pressures could squeeze margins.
These are the main risks that could offset the positive turnaround story.

August 202623 Jul – 8 Oct 2026

▲3▼1

SAPPE turns the corner: profit growth returns, brokers raise targets

Q2 revenue up 16%, first profit growth in 7 quarters expected SAPPE's Q2 2026 revenue rose 16% to 1.5 billion baht, with net profit up 3.3%, as Asia and US sales recovered. Brokers now expect Q3 to deliver the first year-on-year profit growth in seven quarters, a sign the worst is over.
This is the core fundamental turnaround driving the stock's re-rating.
Brokers lift targets, cite 16% profit growth and cheap valuation Finansia Syrus raised its target to 44 baht, Krungsri kept Buy at 38.50 baht, and Maybank highlighted SAPPE's 16% profit growth in 2027 with the sector's lowest P/E of 12.2x. Multiple upgrades signal growing analyst confidence.
Broker upgrades and target hikes directly influence investor sentiment and buying.
International expansion and new capacity support 10-15% growth SAPPE is expanding in Asia, the Americas, and Europe, targeting 10-15% revenue growth. A new production line in 2027 will add 25-30% capacity. The Indonesia distributor launch was delayed to early 2027 but remains a major opportunity.
Growth strategy and capacity expansion underpin future earnings potential.
US tariffs and rising sugar costs pose headwinds The US imposed a 12.5% tariff on Thai imports, affecting SAPPE's 11% US revenue exposure. Global sugar prices jumped 21%, and SAPPE is seen as most vulnerable due to its high export share. These pressures could squeeze margins.
These are the main risks that could offset the positive turnaround story.

Latest23 Jul – 8 Oct 2026

▲3▼1

SAPPE turns the corner: profit growth returns, brokers raise targets

Q2 revenue up 16%, first profit growth in 7 quarters expected SAPPE's Q2 2026 revenue rose 16% to 1.5 billion baht, with net profit up 3.3%, as Asia and US sales recovered. Brokers now expect Q3 to deliver the first year-on-year profit growth in seven quarters, a sign the worst is over.
This is the core fundamental turnaround driving the stock's re-rating.
Brokers lift targets, cite 16% profit growth and cheap valuation Finansia Syrus raised its target to 44 baht, Krungsri kept Buy at 38.50 baht, and Maybank highlighted SAPPE's 16% profit growth in 2027 with the sector's lowest P/E of 12.2x. Multiple upgrades signal growing analyst confidence.
Broker upgrades and target hikes directly influence investor sentiment and buying.
International expansion and new capacity support 10-15% growth SAPPE is expanding in Asia, the Americas, and Europe, targeting 10-15% revenue growth. A new production line in 2027 will add 25-30% capacity. The Indonesia distributor launch was delayed to early 2027 but remains a major opportunity.
Growth strategy and capacity expansion underpin future earnings potential.
US tariffs and rising sugar costs pose headwinds The US imposed a 12.5% tariff on Thai imports, affecting SAPPE's 11% US revenue exposure. Global sugar prices jumped 21%, and SAPPE is seen as most vulnerable due to its high export share. These pressures could squeeze margins.
These are the main risks that could offset the positive turnaround story.

Danone SA (BN.PA)

Q3 202622 Jun – 4 Sep 2026

▲4

Danone buys growth brands, beats Q2, strengthens patent

Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.
A concrete deal that adds growth and profit, directly supporting the stock.
Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.
The quarter's results beat expectations and confirm the company is on track.
Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.
A completed deal that expands a fast-growing part of the business.
New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.
Protects a promising new product line, a real positive for future sales.

July 202622 Jun – 4 Sep 2026

▲4

Danone buys growth brands, beats Q2, strengthens patent

Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.
A concrete deal that adds growth and profit, directly supporting the stock.
Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.
The quarter's results beat expectations and confirm the company is on track.
Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.
A completed deal that expands a fast-growing part of the business.
New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.
Protects a promising new product line, a real positive for future sales.

Latest22 Jun – 4 Sep 2026

▲4

Danone buys growth brands, beats Q2, strengthens patent

Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.
A concrete deal that adds growth and profit, directly supporting the stock.
Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.
The quarter's results beat expectations and confirm the company is on track.
Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.
A completed deal that expands a fast-growing part of the business.
New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.
Protects a promising new product line, a real positive for future sales.